Cafepharma Today

October 18 2017 - Merck’s Keytruda helped PD-L1 patients live longer

Merck’s Keytruda helped PD-L1 patients live 30 months longer, Cafepharma users discuss Lilly layoffs, Abbott Q3 earnings, and more - scroll down for the latest news


Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com

Current News

Padding its lung cancer lead, Merck's Keytruda helped PD-L1 patients live 30 months longer
Fierce Pharma
Wednesday, October 18, 2017 - 10:29am
tags:
Merck, Keytruda, PD-L1
Reckitt to reshape as sales growth evaporates
Yahoo/Reuters
Wednesday, October 18, 2017 - 10:23am
tags:
Reckitt Benckiser
[forum discussion]Have the 3500 been identified yet (layoffs at Lilly)
Cafepharma Message Boards
Wednesday, October 18, 2017 - 10:18am
tags:
Eli Lilly, layoffs
Tampering allegations in Johnson & Johnson hip case prompt judge to trigger probe
Mass Device
Wednesday, October 18, 2017 - 10:14am
tags:
JNJ, hip implants, metal-on-metal hip implants, devices, DePuy Ortho
Abbott ticks up as Q3 tops Wall Street’s forecast
Mass Device
Wednesday, October 18, 2017 - 10:10am
tags:
Abbott Labs, earnings, devices
With $500M-plus, a buyout and two new billion-dollar pacts, upstart Vir is ready to roll on infectious diseases
Endpoints
Wednesday, October 18, 2017 - 10:08am
tags:
Vir Biotechnology, George Scangos, Alnylam, Visterra
Hunting an early FDA OK, Ignyta surges on promising snapshot of lung cancer data
Endpoints
Wednesday, October 18, 2017 - 9:24am
tags:
Ignyta, entrectinib, non-small cell lung cancer
Despite notable failures, cancer vaccines are poised for a leap onto the market: expert
Fierce Pharma
Wednesday, October 18, 2017 - 9:06am
tags:
cancer vaccines, Merck, Keytruda, Bristol-Myers Squibb, Opdivo
Healthcare/Pharma: What Millennials Want
Pharma Voice
Wednesday, October 18, 2017 - 8:50am
tags:
millennials
J&J prevails in first talc appeal as judges vacate $72M verdict
Fierce Pharma
Wednesday, October 18, 2017 - 8:46am
tags:
JNJ
Pfizer, NEA back Cydan II’s plans to launch a fresh slate of biotech startups focused on rare genetic diseases
Endpoints
Wednesday, October 18, 2017 - 8:45am
tags:
Pfizer, NEA, Cydan, biotech
Advice for pharma in payer marketing? Ramp up digital, study finds
Fierce Pharma
Wednesday, October 18, 2017 - 8:44am
tags:
payers, digital advertising
Johnson & Johnson says Puerto Rico plants 'fared well' in Maria, but 'intermittent' shortages possible
Fierce Pharma
Tuesday, October 17, 2017 - 8:36pm
tags:
JNJ, Puerto Rico, drug manufacturing, hurricanes, drug shortages
Key senators reach deal on resuming payments to health insurers after Trump blocked them
Stat
Tuesday, October 17, 2017 - 8:32pm
tags:
Senate, insurers, healthcare reform, Donald Trump
Novo's experimental diabetes drug likely to compete with Trulicity
Medical Marketing and Media
Tuesday, October 17, 2017 - 8:29pm
tags:
Novo Nordisk, diabetes, Trulicity, semaglutide
Many questions, few answers in Senate hearing on opaque US drug pricing system
Endpoints
Tuesday, October 17, 2017 - 8:27pm
tags:
drug pricing, Senate, PBMs
Is MannKind's Debt a Ticking Time Bomb?
Motley Fool
Tuesday, October 17, 2017 - 8:25pm
tags:
MannKind, debt
GlaxoSmithKline wins first-ever nod for blockbuster vaccine prospect Shingrix
Fierce Pharma
Tuesday, October 17, 2017 - 8:24pm
tags:
GSK, vaccines, Shingrix, shingles
The Country's Biggest Insurer Got Even Bigger in Q3
Motley Fool
Tuesday, October 17, 2017 - 8:22pm
tags:
Unitedhealth Group, insurers, Medicaid, Medicare
J&J's Remicade stands firm against biosim competition in Q3
Fierce Pharma
Tuesday, October 17, 2017 - 8:21pm
tags:
JNJ, Remicade, biosimilars
[forum discussion]New neuro sales force for Amgen migraine drug erenumab
Cafepharma Message Boards
Tuesday, October 17, 2017 - 12:40pm
tags:
Amgen, drug reps, hirings, migraines, erenumab
New cancer drugs help J&J top profit estimates
Yahoo/Reuters
Tuesday, October 17, 2017 - 10:27am
tags:
JNJ, earnings
J&J is jettisoning two of its promised blockbuster drugs, and it couldn’t come at a worse time
Endpoints
Tuesday, October 17, 2017 - 10:26am
tags:
JNJ, sirukumab, rheumatoid arthritis, talacotuzumab, acute myeloid leukemia
Takeda is beefing up its NASH pipeline with a $470M discovery deal with HemoShear
Endpoints
Tuesday, October 17, 2017 - 10:13am
tags:
Takeda, NASH, drug discovery, HemoShear, R&D
Should Intuitive Surgical Be Worried About Tiny TransEnterix?
Motley Fool
Tuesday, October 17, 2017 - 10:03am
tags:
devices, Intuitive Surgical, Transenterix, robotic surgery, DaVinci Surgical System, Senhance
Orexigen posts a ‘for sale’ sign in the yard as weak Contrave sales raise concerns
Endpoints
Tuesday, October 17, 2017 - 9:50am
tags:
Orexigen, Contrave, M&A
Tom Marino withdraws his name for consideration as drug czar
Stat
Tuesday, October 17, 2017 - 9:49am
tags:
Tom Marino, Donald Trump, opioids, opioid crisis, DEA
Drugmakers begin to up media controls, in bid to clean up digital ad supply
Medical Marketing and Media
Tuesday, October 17, 2017 - 9:48am
tags:
digital advertising, drug ads
Novartis division closing Broomfield operations
Broomfield Enterprise, Colorado
Tuesday, October 17, 2017 - 9:46am
tags:
Novartis, drug manufacturing, Sandoz, generics
3 Drug Stocks Hitting 52-Week Highs
Motley Fool
Tuesday, October 17, 2017 - 9:42am
tags:
Biogen, Halozyme Therapeutics, Ionis Pharmaceuticals

Latest Pharmagather Articles

How Data Science & Network Analytics Can Help Pharma Shift from Brand Centricity to Customer Centricity
pharmexec marketing
How Data Science & Network Analytics Can Help Pharma Shift from Brand Centricity to Customer Centricity
pharmexec marketing
How Data Science and Network Analytics Can Help Pharma Brands Shift from Brand Centricity to Customer Centricity
pharmexec marketing
The Blind Watchmaker’s Workshop
In the Pipeline
Weekly Roundup 9.22.17
eye on fda
Short Chemistry Topics
In the Pipeline
Drug Serialization for DSCSA Compliance Benefits Everyone
pharmexec technology
The Supply Chain: What Price Patient Centricity?
pharmexec technology
Drug Serialization for DSCSA Compliance Benefits Everyone
pharmexec r&d

Latest CP Wire Articles

Users Respond to CNN article on Nuedexta
Fewer pharma job cuts so far in 2017
How Are Whistleblowers Paid
Proove Biosciences Responds to News About FBI Raid
Tips for Your Next Job Interview
UroToday.com, Leading Urology Reference Site, Launches a New Clinical Trials Portal
Physician-Rep Conversation - A Lesson From Cafepharma
MedReps Survey Reveals Best Places to Work in Medical Sales in 2017 (inc. infographic)
Using Real World Evidence to Drive Affordability of Specialty Drugs
Novartis Social Media Network for Patients - Is This a Good Idea
Pharma Jobs from Indeed

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

Pharma and Device News from NASDAQ

Arbutus Presents HBV Data at Upcoming Scientific Conferences
Friday, September 22, 2017 - 4:53pm
Abeona Therapeutics Announces Upcoming Conference Participation
Friday, September 22, 2017 - 8:45am
ProQR Presents in vivo Proof of Concept Data for the Axiomer® RNA Editing Platform Technology
Thursday, September 21, 2017 - 7:05am
ProQR to Present at Two Investor Conferences in September
Thursday, September 21, 2017 - 7:00am
Oxygen Concentrators and Cylinders Market worth over $4.5 billion by 2024: Global Market Insights, Inc.
Thursday, September 21, 2017 - 7:00am
BioCryst’s RAPIVAB® (peramivir injection) Receives FDA Approval for a Pediatric Indication
Thursday, September 21, 2017 - 6:00am
Amarin to Present at Cantor Global Healthcare Conference
Wednesday, September 20, 2017 - 4:30pm
Arbutus’ LNP Licensee Alnylam Announces Positive Phase 3 Results for LNP-Enabled Patisiran Program
Wednesday, September 20, 2017 - 12:22pm
Lightstone Ventures Closes New Life Sciences Fund at $250 Million
Wednesday, September 20, 2017 - 7:27am
Achillion to Present at the 2017 Leerink Partners Rare Disease Roundtable Series
Wednesday, September 20, 2017 - 6:05am

Breaking Healthcare News - powered by Seeking Alpha

Maine's Collins puts another nail in coffin of Obamacare repeal
Sunday, September 24, 2017 - 11:56am
Stocks to Watch Next Week
Saturday, September 23, 2017 - 9:49am
FDA rejects Allergan's application for expanded use of antipsychotic med Vraylar
Friday, September 22, 2017 - 5:01pm
FDA approves Agilent's Keytruda companion diagnostic test for gastric cancer
Friday, September 22, 2017 - 4:51pm
Rennova to reverse split shares 1:15 on October 5
Friday, September 22, 2017 - 4:45pm
Atossa files for $50M mixed shelf offering
Friday, September 22, 2017 - 4:32pm
FDA rejects J&J's marketing application for RA med sirukumab, more safety data needed
Friday, September 22, 2017 - 4:27pm
Valeritas inks $20M stock purchase agreement with Aspire Capital
Friday, September 22, 2017 - 4:14pm
Novelion unit Aegerion to admit guilt and pay $36M to settle Juxtapid case
Friday, September 22, 2017 - 4:07pm
MabVax raises $1.25M in direct offering; shares down 12%
Friday, September 22, 2017 - 3:43pm

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.